On Tuesday, Cellebrite DI Ltd (NASDAQ: CLBT) was -1.22% drop from the session before settling in for the closing price of $19.71. A 52-week range for CLBT has been $10.24 – $26.30.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Technology Sector giant was 19.94%. When this article was written, the company’s average yearly earnings per share was at 122.19%. With a float of $87.60 million, this company’s outstanding shares have now reached $234.52 million.
Let’s determine the extent of company efficiency that accounts for 1167 employees. In terms of profitability, gross margin is 84.4%, operating margin of 14.19%, and the pretax margin is -68.79%.
Cellebrite DI Ltd (CLBT) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Cellebrite DI Ltd stocks. The insider ownership of Cellebrite DI Ltd is 63.42%, while institutional ownership is 37.54%. The most recent insider transaction that took place on Mar 25 ’25, was worth 376,996. Before that another transaction happened on Mar 19 ’25, when Company’s Officer proposed sale 15,680 for $18.94, making the entire transaction worth $296,920.
Cellebrite DI Ltd (CLBT) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 122.19% per share during the next fiscal year.
Cellebrite DI Ltd (NASDAQ: CLBT) Trading Performance Indicators
You can see what Cellebrite DI Ltd (CLBT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.62. Likewise, its price to free cash flow for the trailing twelve months is 37.72.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.40, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 0.36 in one year’s time.
Technical Analysis of Cellebrite DI Ltd (CLBT)
Looking closely at Cellebrite DI Ltd (NASDAQ: CLBT), its last 5-days average volume was 1.0 million, which is a drop from its year-to-date volume of 1.61 million. As of the previous 9 days, the stock’s Stochastic %D was 55.26%. Additionally, its Average True Range was 0.77.
During the past 100 days, Cellebrite DI Ltd’s (CLBT) raw stochastic average was set at 32.58%, which indicates a significant decrease from 62.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 30.69% in the past 14 days, which was lower than the 45.54% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.86, while its 200-day Moving Average is $18.83. However, in the short run, Cellebrite DI Ltd’s stock first resistance to watch stands at $19.77. Second resistance stands at $20.06. The third major resistance level sits at $20.47. If the price goes on to break the first support level at $19.07, it is likely to go to the next support level at $18.66. Now, if the price goes above the second support level, the third support stands at $18.37.
Cellebrite DI Ltd (NASDAQ: CLBT) Key Stats
There are 239,470K outstanding shares of the company, which has a market capitalization of 4.66 billion. As of now, sales total 401,200 K while income totals -283,010 K. Its latest quarter income was 109,050 K while its last quarter net income were 19,270 K.
